Lack of Truncated IFITM3 Transcripts in Cells Homozygous for the rs12252-C Variant That is Associated with Severe Influenza Infection

Journal of Infectious Diseases

Volumn 217, Issue 2, 2018, Pages 257-262

  Makvandi Nejad, Shokouh ^a   Laurenson Schafer, Henry ^a   Wang, LiLi ^a   Wellington, Dannielle ^a   Zhao, Yan ^b,c   Jin, Boquan ^d   Qin, Ling ^b,c   Kite, Kerry ^a   Moghadam, Hooman K ^e   Song, Chaojun ^d   Clark, Kevin ^f   Hublitz, Philip ^a   Townsend, Alain R ^b   Wu, Hao ^c   McMichael, Andrew J ^a,b   Zhang, YongHong ^b,c   Dong, Tao ^a,b,c  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c CAPITAL MEDICAL UNIVERSITY   (China)

^d FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^e NOFIMA   (Norway)

^f UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

IFITM3; influenza A virus; rs12252

Indexed keywords

AMINO ACID; INTERFERON INDUCED TRANSMEMBRANE 3; MEMBRANE PROTEIN; UNCLASSIFIED DRUG; IFITM3 PROTEIN, HUMAN; MESSENGER RNA; RNA BINDING PROTEIN;

ARTICLE; CONTROLLED STUDY; DENDRITIC CELL; DISEASE ASSOCIATION; DISEASE SEVERITY; GENETIC TRANSCRIPTION; GENETIC VARIATION; GENOTYPE; HIGH THROUGHPUT SEQUENCING; HOMOZYGOSITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; IC50; INFLUENZA; INFLUENZA A (H1N1); INFLUENZA A VIRUS; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; RNA SEQUENCE; SINGLE NUCLEOTIDE POLYMORPHISM; GENETICS; IMMUNOLOGY; INFLUENZA A VIRUS (H1N1); ISOLATION AND PURIFICATION; MONONUCLEAR CELL; PATHOLOGY; SEQUENCE ANALYSIS; UNITED KINGDOM; VIROLOGY;

DENDRITIC CELLS; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA, HUMAN; LEUKOCYTES, MONONUCLEAR; MEMBRANE PROTEINS; POLYMORPHISM, SINGLE NUCLEOTIDE; RNA, MESSENGER; RNA-BINDING PROTEINS; SEQUENCE ANALYSIS, RNA; UNITED KINGDOM;

EID: 85040590942     PISSN: 00221899     EISSN: 15376613     Source Type: Journal    
DOI: 10.1093/infdis/jix512     Document Type: Article

References (15)

1. Brass AL, Huang IC, Benita Y, et al. The IFITM proteins mediate cellular resistance to influenza A H1N1 virus, West Nile virus, and dengue virus. Cell 2009; 139: 1243-54.
2. Everitt AR, Clare S, Pertel T, et al.; GenISIS Investigators; MOSAIC Investigators. IFITM3 restricts the morbidity and mortality associated with influenza. Nature 2012; 484:519-23.
3. Zhang YH, Zhao Y, Li N, et al. Interferon-induced transmembrane protein-3 genetic variant rs12252-C is associated with severe influenza in Chinese individuals. Nat Commun 2013; 4:1418.
4. Zhang Y, Makvandi-Nejad S, Qin L, et al. Interferoninduced transmembrane protein-3 rs12252-C is associated with rapid progression of acute HIV-1 infection in Chinese MSM cohort. AIDS 2015; 29:889-94.
5. Wang Z, Zhang A, Wan Y, et al. Early hypercytokinemia is associated with interferon-induced transmembrane protein-3 dysfunction and predictive of fatal H7N9 infection. Proc Natl Acad Sci USA 2014; 111:769-74.
6. Xu-Yang Z, Pei-Yu B, Chuan-Tao Y, et al. Interferoninduced transmembrane protein 3 inhibits hantaan virus infection, and its single nucleotide polymorphism rs12252 influences the severity of hemorrhagic fever with renal syndrome. Front Immunol 2016; 7:535.
7. Lee N, Cao B, Ke C, et al. IFITM3, TLR3, and CD55 genes SNPs and cumulative ge-netic risks for severe outcomes in Chinese patients with H7N9/H1N1pdm09 influenza. J Infect Dis 2017; 216:97-104.
8. Mills TC, Rautanen A, Elliott KS, et al. IFITM3 and susceptibility to respiratory viral infections in the community. J Infect Dis 2014; 209:1028-31.
9. Lopez-Rodriguez M, Herrera-Ramos E, Sole-Violan J, et al. IFITM3 and severe influenza virus infection. No evidence of genetic association. Eur J Clin Microbiol Infect Dis 2016; 35:1811-7.
10. Randolph AG, Yip WK, Allen EK, et al. Evaluation of IFITM3 rs12252 association with severe pediatric influenza infection. J Infect Dis 2017; 216:14-21.
11. Jia R, Pan Q, Ding S, et al. The N-terminal region of IFITM3 modulates its antiviral activity by regulating IFITM3 cellular localization. J Virol 2012; 86:13697-707.
12. Compton AA, Roy N, Porrot F, et al. Natural mutations in IFITM3 modulate post-translational regulation and toggle antiviral specificity. EMBO Rep 2016; 17:1657-71.
13. Foster TL, Wilson H, Iyer SS, et al. Resistance of transmitted founder HIV-1 to IFITM-mediated restriction. Cell Host Microbe 2016; 20:429-42.
14. Williams DE, Wu WL, Grotefend CR, et al. IFITM3 polymorphism rs12252-C restricts influenza A viruses. PLoS One 2014; 9:e110096.
15. Powell TJ, Silk JD, Sharps J, Fodor E, Townsend AR. Pseudotyped influenza A virus as a vaccine for the induction of heterotypic immunity. J Virol 2012; 86:13397-406.